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Particle therapy exploits the energy deposition pattern of hadron beams. The narrow Bragg Peak at 
the end of range is a major advantage but range uncertainties can cause severe damage and require 
online verification to maximise the effectiveness in clinics. In-beam Positron Emission Tomography 
(PET) is a non-invasive, promising in-vivo technique, which consists in the measurement of the β+ 
activity induced by beam-tissue interactions during treatment, and presents the highest correlation of 
the measured activity distribution with the deposited dose, since it is not much influenced by biological 
washout. Here we report the first clinical results obtained with a state-of-the-art in-beam PET scanner, 
with on-the-fly reconstruction of the activity distribution during irradiation. An automated time-
resolved quantitative analysis was tested on a lacrimal gland carcinoma case, monitored during two 
consecutive treatment sessions. The 3D activity map was reconstructed every 10 s, with an average 
delay between beam delivery and image availability of about 6 s. The correlation coefficient of 3D 
activity maps for the two sessions (above 0.9 after 120 s) and the range agreement (within 1 mm) prove 
the suitability of in-beam PET for online range verification during treatment, a crucial step towards 
adaptive strategies in particle therapy.
Particle therapy, one of the most promising cancer therapy techniques, is based on the dose delivered by charged 
particles, such as protons or heavier ions, which can be shaped in narrow beams. Their main advantage lies in 
their energy deposition pattern in matter, which exhibits the so-called Bragg Peak (BP) at the end of range, where 
the majority of the energy is released. Since the BP is very narrow, range uncertainties, due for example to dose 
calculation approximations in the treatment planning or to patient mispositioning and/or anatomical modifi-
cations at the time of irradiation, could cause severe damage to the patient, especially for tumours very close to 
critical organs. Presently, clinical facilities design treatment plans based on relatively large margins (up to 15 mm, 
depending on the particle range) and multi-directional delivery, so as to minimise the risk of critical damage. The 
implementation of reliable online range verification methods could allow both reduction of safety margins and 
dose escalation, leading to a full exploitation of the advantages of particle therapy in clinics. In-beam, off-beam 
or after-treatment Positron Emission Tomography (PET), secondary charged particles tracking, and prompt pho-
ton monitoring techniques have already been exploited clinically by various centres1–7. In particular, PET-based 
monitoring techniques rely on positron-emitting (β+) radioactive isotopes, which are produced by the target and, 
in the case of ions with Z ≥ 5, also by the projectile nuclear fragmentation8. The low-energy positrons emitted 
annihilate at rest in the body tissues producing 511 keV back-to-back photon pairs, a signal that can be exploited 
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to monitor the treatment with a PET scanner9. Although the correlation between the measured activity and deliv-
ered dose is not straightforward1,10, the reconstructed activity distribution gives an insight into the coherence of 
the planned and delivered treatment.
In-beam PET, not being much influenced by biological washout associated to the metabolism, such as per-
fusion and diffusion through functional pathways, presents the highest correlation of the measured activity 
distribution with the deposited dose11; however, its past clinical implementations6,12 relied on sub-optimal instru-
mentation2. Here we report the first clinical results obtained with a state-of-the-art in-beam PET scanner, based 
on solid-state photodetectors and custom front-end electronics, time-resolved analysis and an on-the-fly recon-
struction of the activity distribution during irradiation.
The INSIDE (Innovative Solutions for In-beam DosimEtry in hadrontherapy) in-beam PET scanner features 
two planar heads of 10 × 25 cm2 active area, each one made of 2 × 5 detection modules with 16 × 16 Lutetium Fine 
Silicate (LFS) crystals coupled 1:1 to Hamamatsu MPPCs, resulting in 25602 lines of response. The PET heads are 
positioned above and below the patient, at a relative distance of 60 cm; therefore the Field Of View (FOV) covers 
25 cm along the beam direction, 10 and 22 cm along the transverse and vertical directions, respectively. The detec-
tor resolution on the photon interaction point in the crystal is in the order of the mm, thans to the 1-to-1 coupling 
between the crystals (3.2 mm pitch) and the SiPM.
The TOFPET ASIC13 is used to read out information about the energy and time of each event. The events are 
processed by 20 Xilinx Spartan-6 Field Programmable Gate Arrays and transmitted with UDP protocol through 
Gigabit Ethernet links to a HP Proliant data acquisition server which implements the online coincidence finding 
and reconstructs the PET images on-the-fly, in about 6 s. The scanner is mounted on a mobile support and the dis-
tance between the PET heads can be adjusted to reduce possible interference with the treatment room equipment. 
A detailed system description is available in14.
The scanner has been installed in one of the Italian National Center of Oncological Hadrontherapy (CNAO)15 
synchrotron facility treatment rooms with a fixed horizontal beam line. The in-beam PET was tested during 2016 
with polymethyl methacrylate (PMMA) and anthropomorphic phantoms14,16 and its response was thoroughly 
characterized.
The scanner setup used during system characterization was adopted on December, 1st and 2nd 2016 to perform 
the first online monitoring test during a patient treatment session. The scanner support was positioned between 
the beam nozzle and the patient bed, by manual alignment with the treatment room lasers (Fig. 1). In order to 
avoid interference with patient handling and X-ray patient position verification, the scanner was manually put in 
place just before the field delivery and removed shortly afterwards.
The patient (male, 56 years old), affected by carcinoma of the right lacrimal gland, was treated with protons 
in 30 daily sessions of 2.2 GyE each. The treatment was delivered with a fixed horizontal beam line (IEC Gantry 
Angle = 90°), with two beam fields. The INSIDE in-beam PET system was tested with the first irradiated beam 
field, roughly corresponding to a half session dose. Figure 2a shows the planned dose distribution to be delivered 
during the monitored field, superimposed to the patient’s CT. The clinical target volume (CTV) is also shown.
Figure 1. The INSIDE in-beam PET in one of the CNAO treatment rooms. The mobile support is placed 
between the horizontal beam line nozzle and the patient bed, ready for acquisition. The beam direction is shown 
in the picture.
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On the days of the INSIDE in-beam PET acquisition, the patient underwent fractions n. 28 and 29 of his ther-
apy. In-beam PET acquisition was performed during the field irradiation with the patient bed positioned parallel 
to the beam axis (IEC Patient Support Angle equal to 270°). The PET heads were placed as in Fig. 1. The distance 
of the beam isocenter from the upper and lower detector active surface was 32.7 cm and 27.6 cm, respectively. The 
configuration was not symmetric because of mechanical constraints related to the positioning of the patient bed.
The aim of the present analysis is to demonstrate the feasibility of online monitoring with PET in a clinical 
environment and the reproducibility of the measurements. Therefore, the analysis is carried on comparing the 
activity acquired in the two treatment sessions.
Results
On-the-fly reconstruction. In the measured beam field, 3.7∙1010 protons were delivered with an energy 
range from 66.3 to 144.4 MeV, divided in 56 pencil-beam scanning slices, with a 3.12 cm water-equivalent thick 
range shifter positioned along the beam axis, 11 cm from the isocenter. The irradiated volume maximum cross 
dimension with respect to the beam axis was about 10.6 × 10.0 cm2. The duration of the beam field irradiation 
was about 240 s; the in-beam PET acquisition lasted 30 s more, corresponding to the time necessary to access the 
room, remove the scanner and start preparing for the administration of the second field.
For both acquisitions, the PET images were reconstructed on-the-fly every 10 s from the beginning of the 
treatment, as seen in the video (included as supplementary information) that compares the two treatment ses-
sions, so as to analyse the time evolution of the activity distribution while progressively integrating the signal and 
prove the online monitoring feasibility. The reconstructed images were available for analysis with a delay of about 
6 s, (corresponding to about 1.5 accelerator cycles – see section 4.1), which would allow treatment interruption in 
case a range error was detected. The beam is delivered with increasing energy, in periods of actual particle deliv-
ery (in-spill) of about 1 s, followed by intervals (inter-spill) of about 3 s. As explained in the Methods section, the 
reconstruction was made taking into account only the coincidences acquired during the inter-spill phase. A final 
image including the whole treatment and 30 s after-treatment was also reconstructed.
Figure 2. (a) Treatment plan and set up. Axial (left), coronal (centre) and sagittal (right) sections of the patient 
CT with the planned dose distribution to be delivered in the beam field monitored with the INSIDE in-beam 
PET system and the Clinical Target Volume (CTV) superimposed in white. (b) Time Evolution of a 2D slice of 
the detected beam-induced activity superimposed to the patient Computed Ttomography (CT) used for dose 
planning. The top and bottom rows refer to the first (December, 1st, 2016), and second (December, 2nd, 2016) 
acquisition days, respectively. The shown images correspond to 3D activity map reconstructions at the end of 
every minute, starting from the beginning of the treatment. An additional image corresponding to the whole 
treatment plus 30 s after-treatment is also shown. The image look-up tables refer to different intensity scales 
because of the different amounts of data integrated during the time intervals.
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Figure 2b shows some of the images reconstructed during treatment, as a function of the acquisition time 
(every 60 s), superimposed with the patient Computed Tomography (CT) used for dose planning. A median filter 
with a 11.2 × 11.2 × 11.2 mm3 kernel (7 × 7 × 7 voxels) was applied to the in-beam PET images in order to min-
imise low statistics and shot noise biases.
The shape variations of 3D activity images reconstructed up to about 60 s, related to the collected statistics, are 
clearly visible between the two acquisitions. As the treatment progresses, the integrated activity increases and the 
images series are more and more similar, as confirmed by the quantitative evaluation.
As an example, the activity profiles along the beam direction (z) for three different time intervals are shown in 
Fig. 3. The profiles, calculated by projecting along the beam axis a 1.6 × 1.6 mm2 area (1 × 1 voxel) in the trans-
verse plane (xy), clearly show that the range progresses with time (as expected, since the beam energy increases 
during the delivery) and that the fall-off, although spread over a few cm, is smooth enough to allow a comparison 
between different treatment sessions.
Time-resolved analysis. In this work, three analyses – described in detail in section 4 – were imple-
mented, labelled as Pearson’s correlation coefficient (PCC), Beam’s Eye View (BEV) and Overall View (OV). All 
of them take into account only the image volume actually irradiated by the beam. The results obtained on the 
time-resolved image series acquired in the two consecutive days provide a first evaluation of the INSIDE in-beam 
PET performance, which will be studied in depth in the future with the evaluation of a wide range of patients.
The PCC analysis was implemented to obtain an overall index quantifying the linear correlation between the 
intensity of the image series from the two-days. The PCC index is not sufficient to rule out local range anomalies, 
which are better addressed with the BEV and OEV methods, but it provides a fairly simple first order evaluation 
of the compliance between the expected and actual activity distributions. The PCC was computed in a Region 
Of Interest (ROI), defined in detail in the Methods section, that includes the activity distal fall-off inside the 
patient body17. Figure 4a shows the PCC evolution as a function of time. After 120 s the PCC reaches values above 
0.90, showing good agreement between acquisitions, and its maximum (0.96) corresponds to the last couple of 
acquired images.
Since the main goal of beam monitoring is to assess in-vivo the particle range, the BEV method analyses 
the 3D activity distribution taking into account the direction of the beam (Fig. 4b). This method evaluates the 
differences in the activity range between two PET images along the beam axis. After 120 s, the average range dif-
ference is in the interval (−2.2, +3.5) mm. The BEV method is specifically prone to two uncertainty sources: low 
statistics, which results in reduced sensitivity, and repeatability of the scanner positioning on the two acquisitions 
(presently, about 1–2 mm on the horizontal plane).
The OV method, on the other hand, circumvents these uncertainty sources: it compares images without any 
preferred direction, by finding the minimum distance point-by-point of the two contour surfaces. Results after 
120 s (Fig. 4c) indicate sub-millimetric agreement of the average surface distance until the end of treatment.
The BEV and OV methods do not provide reproducible information until the signal acquisition time is longer 
than 120 s because the integrated activity is not statistically significant. Further analysis will be conducted to eval-
uate the feasibility and advantages given by PET images reconstructed with integration times shorter than 60 s.
Discussion
Until today, the most significant clinical implementation of in-beam PET was at the GSI synchrotron Helmholtz 
Centre for Heavy Ion Research in Darmstadt, Germany, between 1997 and 200812, to monitor carbon ion therapy. 
Among the many important contributions of this study is the significant improvement of the model used to con-
vert CT HU map into human tissues and densities18. Another installation is presently in clinical use at HIMAC 
in Kashiwa, Japan9; it is well integrated within the cyclotron gantry, but it acquires data only after the irradiation. 
Several other systems are under construction or being commissioned6,19.
The INSIDE scanner presented here relies on state-of-the-art technologies, and is the first, to our knowledge, 
able to demonstrate that in-beam PET imaging can be effectively used to monitor proton therapy in clinical condi-
tions, while delivering the treatment. Once the statistical significance required for a meaningful analysis is reached 
(about 2 minutes after the beam delivery started), the online feedback on the treatment compliance is available with 
a delay of 6 s, enough to implement emergency procedures to prevent unexpected damage to the patients.
Figure 3. Reconstructed activity profiles along the beam direction (z) for 1 pixel in the transverse plane (xy), at 
three different time intervals corresponding to one half of the delivery (120 s), the end of treatment (240 s) and 
the end of acquisition (270 s). The distributions are normalised to their maximum activity value.
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Moreover, an automated time-resolved analysis was proposed, which is a fundamental goal to achieve 
on-the-fly quantitative treatment verification. In literature, the evaluation of the treatment accuracy by means of 
PET images has already been investigated with different strategies. Most of the published works focused on the 
evaluation of the range considering the distal activity fall-off6,20–22, or otherwise relied on visual analysis5. Among 
them, quantitative approaches aim to determine the activity range inside the patient body by thresholding or min-
imization/optimization techniques23. Our automated time-resolved analysis shows a strong correlation between 
the two image series (PCC > 0.9, and average surface distance < 1 mm after 120 s). This result is in accordance to 
the expected outcome, since the acquisitions refer to two consecutive treatment days, and no relevant anatomi-
cal difference was expected, but it also demonstrates that, after about half treatment, the in-beam PET signal is 
already significant and can be used to detect abnormalities.
After the successful first in-vivo test, the scanner mechanical support is being revised in order to integrate it 
more smoothly in the clinical workflow. The primary reason is to shorten the positioning time and hence avoid 
unnecessary extension of the patient immobilization time; also, the new holder will lead to a more accurate 
positioning (of the order of 1 mm, while presently the uncertainty in the horizontal plane is about 2 mm). The 
revised mechanics will avoid the interference with the bed positioning and will allow improvements in the results 
in terms of statistical significance (by extending the number of studied patients and fractions), and accuracy, for 
both proton and carbon ion therapy.
The simulation of the 3D-activity distribution induced by the delivered treatment24,25 is being refined, and it 
will be used as prior knowledge and serve as a reference for comparison with the experimental measurements at 
the beginning of the treatment cycle12.
A clinical trial focused on evaluating the INSIDE performance on a cohort of patients will start in 2018. The 
parameters used in the PCC, BEV and OV methods will be optimised and the range variations for different treat-
ment plans, along their longituinal evolution, will be measured.
Figure 4. (a) Pearson’s Correlation Coefficient calculated for each couple of PET images, reconstructed every 
10 s, as a function of time. (b) Mean difference (black) and standard deviation (white) calculated with the BEV 
method. (c) Mean difference (black) and standard deviation (white) calculated with the OV method.
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With the new mechanical layout, the clinical workflow will start with the patient positioning procedure, 
followed by the placement of the INSIDE scanner and the treatment delivery. The limitations related to the 
sub-otpimal spatial resolution on the vertical coordinate will be addressed by integrating the time-of-flight infor-
mation in the reconstruction. An optimisation of the front-end electronics time resolution will also help reducing 
the background caused by prompt photons random coincidences in the energy range of the photopeak and could 
allow the use of data taken during the spill delivery to improve the statistics and shorten the time needed to obtain 
the first reliable 3D activity map.
Methods
The clinical study was performed at the CNAO facility (Pavia, Italy) in accordance with relevant guidelines and 
regulations and was approved by the CNAO ethics committee (request number 20170011630); the informed 
consent was obtained from the participant. No information or images that could lead to identification of the 
participant is present in this work.
The datasets generated and analysed during the current study are available from the corresponding author on 
reasonable request.
Data selection and image reconstruction. The CNAO synchrotron beam delivery is conducted using an 
intensity-controlled raster scanning technique, with increasing energy and a characteristic time structure defined 
by about 1s-long time intervals in which the particles bunches are actually delivered (called in-spill), and about 
3s-long time intervals where the beam is off (inter-spill)26. During the tests with phantoms aimed at the scanner 
characterization27,28, the INSIDE in-beam PET system efficiently acquired in list mode and reconstructed data in 
both in- and inter-spill conditions.
In-spill is dominated by prompt photons and neutron radiation and the single event rate detected during 
the clinical acquisition was higher than inter-spill by almost a factor 30. Data quality is inherently lower during 
in-spill, since pair production is originated also by prompt radiation, which is less correlated to the irradiated 
volume with respect to β+ decay. Hence coincidence data was selected from inter-spill only by applying a thresh-
old on the acquisition rate. About 7.6 ∙ 104 coincidences were left for the activity image reconstruction after a 
270s-long acquisition time interval.
A maximum likelihood expectation maximization (MLEM) algorithm with 5 iterations was used to recon-
struct time-resolved activity images29. Reconstruction time takes about 2 to 5 seconds. The attenuation correction 
was applied, using the CT acquired for treatment30.
Analysis methods. All the analysis methods reported in this section were implemented in C++ with ITK 
libraries [www.itk.org].
Pearson Correlation Coefficient (PCC). The PCC was evaluated by calculating the correlation coefficient in a 
Region Of Interest (ROI) that includes the activity distal fall-off17. Due to the complex geometrical shape of the 
treated volume, the ROI was defined by considering the voxels between the first voxel with intensity larger than 
95% and the last voxel with intensity larger than 25% of the maximum value of the profile along the beam direc-
tion. In the ROI definition, only the irradiated volume (i.e., the volume corresponding to the surface through 
which the beam passed during the treatment) was taken into account. Since the selected ROI in the two PET 
images must be the same in order to calculate the PCC, the logic union of the individual custom ROIs was used.
Activity mask extraction for the BEV and OV methods. In order to remove the background noise and identify 
the activity range inside the patient body, the 3D activity distribution was analysed as follows. An activity mask 
is extracted by applying a threshold filter tunable to the maximum activity intensity of each image (set to 10% in 
the present analysis), coupled to erosion and dilation filters to obtain a fully connected volume. Because of the 
low acceptance angle of the in-beam PET scanner planar geometry, a poor resolution in the reconstruction of 
the activity position along the direction between the two PET heads was expected. To overcome this intrinsic 
limitation and in agreement with procedures reported in literature1,5,6, the difference in activity range in BEV and 
OV methods was evaluated solely in the volume in which the proton beam was actually delivered, by using the 
time-dependent information given by the dose delivery system.
Beam’s eye view (BEV). The Beam’s eye view method aims to define the activity range from the beam’s point of 
view, and, therefore, takes into account in the image only the actually irradiated volume. The starting and ending 
point of the activity range are calculated, for each voxel belonging to the transversal plane with respect to the 
beam direction, by analysing the activity mask contour. The activity range values for the two treatment sessions 
were then compared by evaluating the average and standard deviation of their difference. Thanks to the INSIDE 
in-beam PET system capability to obtain time-resolved image series, the BEV analysis was performed for each 
image reconstructed at different time intervals, in order to study the time evolution of the range difference indi-
cators. The observables are not influenced by shot noise thanks to the robustness of the procedure for the activity 
mask extraction. They are instead sensitive to shifts of the PET scanner working position, which is presently 
settled manually.
Overall view (OV). To partially overcome uncertainties due to the positioning procedure of the mechanical 
support, which did not allow a precise alignment of the detector with the beam, an analysis independent of the 
beam direction was implemented. In the OV analysis, the activity mask contours were used to compare in time 
the images acquired in the two consecutive sessions, considering only data referring to the actual irradiated 
region (same as in the BEV method). The fundamental difference from the previous method is that the contour 
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comparison takes into account every 3D possible direction to determine the minimum Euclidean distance, voxel 
by voxel, between contours. The average and standard deviation of the contour differences are expected to be 
smaller than the range difference indicators obtained with the BEV method because the OV analysis is less sen-
sitive to tilts or translations in the detector working position between the two acquisition sessions. Thanks to the 
activity mask extraction procedure, this method is also weakly influenced by shot noise.
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